top of page
Image by airfocus

We Put Our Science to Work for Patients

We’re transforming discovery into medicine, pioneering new possibilities in Immunology, Oncology, Neuroscience, Rare Disease, and beyond.

Innovation, inspired by real people

See how real lives — not just conditions — shape our science.

Face Paint

Areas of Focus: At a Glance

Finding innovative solutions for unmet medical needs is at the heart of what we do. Our ideas and research help save lives.

Image by National Cancer Institute

Oncology

Since 2023, Genventis have collaborated with patient on a variety of solid tumors and blood cancer disorders such as lymphoma, leukemia, multiple myeloma, aplastic anemia and sickle cell anemia. We possess specialized expertise in hematopoietic stem cell transplantation (HSCT), cellular therapy and gene therapy.

Image by National Cancer Institute

Cardiovascular & Metabolic

We focus on developing innovative therapies that address the underlying causes of cardiovascular and metabolic diseases, aiming to improve long-term health outcomes and quality of life. Our work spans conditions such as heart failure, type 2 diabetes, and dyslipidemia, with the goal of delivering meaningful impact for patients and healthcare providers alike.

Lasers are used to position a patient mo

Neuroscience

Clients leverage a broad range of expertise in neurological and psychiatric disorders possessed by our neuroscience therapeutic research unit. We have significant experience in traumatic brain injury, stroke, epilepsy, autism, depression, schizophrenia and substance use disorders.

Image by Ed Us

Vaccines and Infectious Diseases

As a biotech company,  Geventis has worked on nearly every epidemic and pandemic since our founding in 2023, including HIV-AIDs, Zika Virus, Ebola, SARS, MERS, H1N1, and COVID-19.

woman's face_edited_edited_edited.jpg

Immunology

Patients seek Genventis’s  respiratory and immunology clinical research services for a variety of disorders including age-related rheumatoid arthritis, COPD, SLE and autoimmune disease.

Image by National Cancer Institute

Rare Disease

We are committed to discovering and developing treatments for rare and underserved conditions, bringing hope where options are limited. Our work focuses on conditions such as Pompe disease, Gaucher disease, and Duchenne muscular dystrophy, aiming to transform lives through innovative and targeted therapies.

Participate in a Trial

To learn more about how Genventis can help you with biostatistical analysis, please contact us.

bottom of page